InsidersTradesSigma
Track the メディシノバ・インク stock price and the full directors' dealings record of the company, a listed equity based in Japan. Shares trade on the JP market, under the supervision of EDINET (Japan FSA). Market capitalisation: €10.6bn. The latest transaction was disclosed on 27 February 2024 (Holding update). Among the most active insiders: Yuichi Iwaki. Every trade is accessible without an account.
Analysts rate メディシノバ・インク Strong Buy (bullish).
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Medicinova, Inc. 是一家生物制药公司，专注于开发神经系统疾病和精神疾病的治疗方法。该公司在东京证券交易所上市，股票代码为 XTKS。